After inhalation of infectious particles, Cryptococcus neoformans resides in the alveolar
spaces, where it can survive and replicate in the extracellular environment. This yeast has …

The fungal pathogen Cryptococcus neoformans (C. neoformans) forms yeast cells of
different sizes and morphological characteristics during infection. These features are usually …

Cryptococcus is an invasive fungus that seriously endangers human life and health, with a
complex and well-established immune-escaping mechanism that interferes with the function …

Cryptococcus neoformans is a pathogenic yeast and a major cause of opportunistic infection
in AIDS patients. It is commonly found in an acapsular form in the environment, and infection …

Cryptococcus neoformans is a facultative intracellular pathogen. The most distinctive feature
of C. neoformans is a polysaccharide capsule that enlarges depending on environmental …

Regular protocols for the isolation of fungal extracellular vesicles (EVs) are time-consuming,
hard to reproduce, and produce low yields. In an attempt to improve the protocols used for …

Extracellular vesicles (EVs) are a heterogeneous group of lipid membrane-enclosed
compartments that contain different biomolecules and are released by almost all living cells …

Cryptococcus neoformans, an encapsulated fungal pathogen, causes meningoencephalitis
in immunocompromised patients. Recent in vivo studies have demonstrated that C …

Although morphological transitions (such as hyphae and pseudohyphae formation) are a
common feature among fungi, the encapsulated pathogenic yeast Cryptococcus neoformans …

Extracellular vesicle (EV) release in fungi was described for the first time in 2007 in the
yeastlike pathogen Cryptococcus neoformans [1]. Since then, the phenomenon of EV …